Cargando…

Survival and prognosis of young adults with gastric cancer

OBJECTIVES: Survival data for young adults (YA) with gastric cancer is conflicting and scarce in Brazil. The aim of this study was to compare the clinicopathological factors and survival rates of younger and older patients with gastric cancer. METHODS: Hospital registries for 294 gastric cancer pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Cormedi, Marina Candido Visontai, Katayama, Maria Lucia Hirata, Guindalini, Rodrigo Santa Cruz, Faraj, Sheila Friedrich, Folgueira, Maria Aparecida Azevedo Koike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131359/
https://www.ncbi.nlm.nih.gov/pubmed/30281703
http://dx.doi.org/10.6061/clinics/2018/e651s
_version_ 1783354087687847936
author Cormedi, Marina Candido Visontai
Katayama, Maria Lucia Hirata
Guindalini, Rodrigo Santa Cruz
Faraj, Sheila Friedrich
Folgueira, Maria Aparecida Azevedo Koike
author_facet Cormedi, Marina Candido Visontai
Katayama, Maria Lucia Hirata
Guindalini, Rodrigo Santa Cruz
Faraj, Sheila Friedrich
Folgueira, Maria Aparecida Azevedo Koike
author_sort Cormedi, Marina Candido Visontai
collection PubMed
description OBJECTIVES: Survival data for young adults (YA) with gastric cancer is conflicting and scarce in Brazil. The aim of this study was to compare the clinicopathological factors and survival rates of younger and older patients with gastric cancer. METHODS: Hospital registries for 294 gastric cancer patients from a reference cancer hospital in São Paulo, Brazil, were consulted for the retrieval of clinicopathological information and follow-up time. Patients were placed into the following groups: YA (≤40 years; N=71), older adult (OA: 41 to 65 years; N=129) and elderly (E: ≥66 years; N=94). Differences were assessed through Pearson's χ(2) test, Kaplan-Meier analysis, Log rank test and Cox regression. RESULTS: More YA were diagnosed with advanced disease (clinical stage III/IV: 86.7% YA, 69.9% OA, and 67% E); however, fewer E patients underwent surgery (64.3% YA, 72.7% OA, and 52.4% E). The median overall survival among all patients was 16 months, and the overall survival rate was not significantly different among the age groups (p=0.129). There were no significant differences in the disease-free survival rate. Metastatic disease at diagnosis (HR=4.84; p<0.01) was associated with an increased hazard of death for YA. CONCLUSION: Overall survival was similar among age groups. Metastatic disease at diagnosis was the only factor associated with a poorer prognosis in YA. These results suggest that younger patients deserve special attention regarding the detection of early stage disease.
format Online
Article
Text
id pubmed-6131359
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
record_format MEDLINE/PubMed
spelling pubmed-61313592018-09-12 Survival and prognosis of young adults with gastric cancer Cormedi, Marina Candido Visontai Katayama, Maria Lucia Hirata Guindalini, Rodrigo Santa Cruz Faraj, Sheila Friedrich Folgueira, Maria Aparecida Azevedo Koike Clinics (Sao Paulo) Original Article OBJECTIVES: Survival data for young adults (YA) with gastric cancer is conflicting and scarce in Brazil. The aim of this study was to compare the clinicopathological factors and survival rates of younger and older patients with gastric cancer. METHODS: Hospital registries for 294 gastric cancer patients from a reference cancer hospital in São Paulo, Brazil, were consulted for the retrieval of clinicopathological information and follow-up time. Patients were placed into the following groups: YA (≤40 years; N=71), older adult (OA: 41 to 65 years; N=129) and elderly (E: ≥66 years; N=94). Differences were assessed through Pearson's χ(2) test, Kaplan-Meier analysis, Log rank test and Cox regression. RESULTS: More YA were diagnosed with advanced disease (clinical stage III/IV: 86.7% YA, 69.9% OA, and 67% E); however, fewer E patients underwent surgery (64.3% YA, 72.7% OA, and 52.4% E). The median overall survival among all patients was 16 months, and the overall survival rate was not significantly different among the age groups (p=0.129). There were no significant differences in the disease-free survival rate. Metastatic disease at diagnosis (HR=4.84; p<0.01) was associated with an increased hazard of death for YA. CONCLUSION: Overall survival was similar among age groups. Metastatic disease at diagnosis was the only factor associated with a poorer prognosis in YA. These results suggest that younger patients deserve special attention regarding the detection of early stage disease. Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2018-09-11 2018 /pmc/articles/PMC6131359/ /pubmed/30281703 http://dx.doi.org/10.6061/clinics/2018/e651s Text en Copyright © 2018 CLINICS http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.
spellingShingle Original Article
Cormedi, Marina Candido Visontai
Katayama, Maria Lucia Hirata
Guindalini, Rodrigo Santa Cruz
Faraj, Sheila Friedrich
Folgueira, Maria Aparecida Azevedo Koike
Survival and prognosis of young adults with gastric cancer
title Survival and prognosis of young adults with gastric cancer
title_full Survival and prognosis of young adults with gastric cancer
title_fullStr Survival and prognosis of young adults with gastric cancer
title_full_unstemmed Survival and prognosis of young adults with gastric cancer
title_short Survival and prognosis of young adults with gastric cancer
title_sort survival and prognosis of young adults with gastric cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131359/
https://www.ncbi.nlm.nih.gov/pubmed/30281703
http://dx.doi.org/10.6061/clinics/2018/e651s
work_keys_str_mv AT cormedimarinacandidovisontai survivalandprognosisofyoungadultswithgastriccancer
AT katayamamarialuciahirata survivalandprognosisofyoungadultswithgastriccancer
AT guindalinirodrigosantacruz survivalandprognosisofyoungadultswithgastriccancer
AT farajsheilafriedrich survivalandprognosisofyoungadultswithgastriccancer
AT folgueiramariaaparecidaazevedokoike survivalandprognosisofyoungadultswithgastriccancer